BOT - Anything but charting, page-5049

Hi FloatingCity if I had the answer to that I would be a very rich women. I know that we are currently priced for failure and as posted previously I know what forward looking numbers should look like upon FDA approval. However we don’t know the cost of product, the numbers who will actually uptake, the amount insurers will pay so all educated guess work. I have my numbers I am sure Mr. Market will have his own ideas.

I agree that I don’t think the end game is Bot developing their own pipeline. Look at the track record of the management team and previous time spent with other companies. They mostly seem to be builders and sellers.